|
|
|
| |
For Industry-Sponsored Clinical Trials
Submitting your proposal materials to the Clinical Trials
Office has never been easier! Submission process, forms, and
instructions are now available online.
Returning to the Online Submission
Process? Click here to go directly to the online submission
process forms. You will need your UNI and password
to access these forms.
If you prefer to complete the submission materials on paper,
the CTO Submission Package, which contains instructions and
forms, is also available in Microsoft Word. Click here to download the Submission Package
New: Western IRB multi-center trial submission instructions
Click here.
Submission Procedure Overview
Submission of CTO Required
Documents
Submission of Sponsor Documents
CTO Review Process
| • |
The CTO must be notified of a pending trial as soon
as the investigator begins to work with the industrial
sponsors. Clinical investigators are requested
to call the CTO and discuss projects as soon as possible.
|
| • |
All RASCAL proposal data sheets must be entered
into the RASCAL online program; select Clinical
Trials to enter your proposal information. Investigators
should create a RASCAL proposal and enter associated
proposal information online at: https://www.rascal.columbia.edu/props/ptframe.html
|
| • |
The Proposal Data must reflect an updated Conflict
of Interest, HIPAA Compliance, and GCP certification
for each individual involved in the study trial, including
clinical research coordinators.
|
| • |
The IRB submission is also completed via the RASCAL
system at: https://www.rascal.columbia.edu/comply/irbframe.html
|
| |
As an exception to the policy of submitting all
protocol to the Columbia IRB, protocols and associated
documents for Novartis, Amgen/Immunex, or Genentech
protocols should be submitted directly to the CTO.
|
| • |
All other contractual documents must be submitted to
the CTO no later than proposal/project submission
to the Institutional Review Board (IRB)
|
Please note! The study
cannot begin until IRB approval has been received and the
contract has been executed.
| Submission of CTO Required
Documents |
| |
The Clinical Trials Office requires submission
of the following documents to complete your proposal
application. Click on the form name to begin the online
submission process. Please
note! You will need a valid UNI and password to
access the online forms.
Departmental Chairs: click here to review and agree to the Compliance Statement.
|
The Clinical Trials Office has established a dedicated Help Desk for online submissions
at 212-305-9517.
|
1. Compliance
Statement (Preview form)
The Compliance Statement provides information regarding investigator and departmental
liability, and includes the Hospital and University expectations for accounting
responsibilities. Both principal investigator and her/his departmental
chairperson must agree to the Compliance Statement before the submission process
is completed.
2. Tax
Exemption Certification (Preview form)
The Tax Exemption Certification indicates the relevance of the proposed clinical
research to the advancement of the educational and scientific clinical research
missions of the University and Hospital and its importance in the promotion of
the health of the public. This information is then used to assure our tax-exempt
status and as an aid in dispute resolution.
3. Questionnaire (Preview form)
The Questionnaire form collects an information synopsis from the protocol. The
CTO uses this information to identify areas that may need special consideration
during the contracting process.
4. Research
Pharmacy Cost Estimate Request Form
(Preview form)
The Research Pharmacy Cost Estimate Request form allows the Research Pharmacy
to provide investigators with a more accurate estimate of costs associated with
the procurement and distribution of pharmaceuticals. If your proposal does
not require Research Pharmacy assistance, e.g., testing of a new medical device,
continue to the Budget Worksheet and instructions for budget preparation. Please
note: investigators requiring cost estimates from the New York
State Psychiatric Institute’s Research Pharmacy should call the Contracts
Department at (212) 305-3360.
5. Budget Worksheet and Instructions (Preview form)
The CTO Finance department must approve all budgets prior to contract
execution. The budget worksheet and instructions are provided as a guide to improve
discussions with this department. The CTO Finance Budgets team members are continually
apprised of all changes in New York-Presbyterian Hospital ChargeMaster program
and can assist investigators in using the appropriate fees.
6. Hispanic Translation Request Form
(Preview form)
Use the Hispanic Translation Request Form to send documents
that require
translation, modification, or review by the
Hispanic Translation Center.
Click
here
to read instructions.
Hispanic Translation Center staff: click
here
to review requests.
7. Investigational Device Exemption (IDE) Studies
New
The
Centers for Medicare and Medicaid Services
(CMS) requires additional
reporting as a condition for participating in an IDE study. The
principal investigator is responsible for submitting
to
Empire Medicare Services
all necessary information concerning the device and the study.
Click here to read instructions.
|
| Sponsor Documents |
| |
Copies of all correspondence with the Sponsor, including
the name(s) and telephone number(s) of any individual(s)
from the Sponsor with whom the Investigator has been
in contact, should be submitted to the CTO. Documents
are to be mailed to the CTO mailing address.
|
| CTO
Review Process |
| |
After receipt of relevant documents, the CTO will
begin contract negotiations with the Industrial Sponsor. The
contract process is usually completed within four weeks;
previously negotiated contracts, issues regarding publication
rights, indemnification and insurance, however, may
impact the amount of time necessary to complete the
contract. To prevent potential delay in processing
the contract, the CTO needs to receive all contract
documents as soon as possible from industrial sponsors.
When the contract has been negotiated, a copy of the final draft of the contract
will be sent to the Investigator with a Review & Return Sheet. The
Investigator and the Department are asked to review the final draft, make comments
(if applicable), and sign to indicate their approval.
When the contract is signed by the investigator and IRB approval has been granted,
two (2) copies of the Contract Agreement are signed by the HOSPITAL and the UNIVERSITY,
and mailed to the industrial sponsor. The contract is fully executed after
all parties involved in the agreement signs the contract. Copies of the contract
will be archived by the CTO, General Counsel Office of Columbia University, and
the General Counsel Office of New York-Presbyterian Hospital.
After receipt of a fully executed copy of the Agreement,
a University account is opened by the CTO, and post-award correspondence
by industrial sponsors is directed to the CTO Finance-Accounts
Receivable Team. All checks must be made to the Trustees
of Columbia University and can only be endorsed by the University. Deposits
are then transferred to the appropriate investigational accounts.
Access to post-award fund distribution information is available
for current contracts on the Investigator Overview
page of this Web site. |
|
|
|
|
Copyright © 1997-2008 Columbia University Medical Center
|
|